Furthermore, the increasing expression of MSI2 with proximity to tumour, alongside its effects on β-catenin translocation, is consistent with the module-specific enrichment of components involved in formation of the β-catenin:TCF-transactivating complex. Here, HNF4A is linked to neoplasm.